Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 159.29%5.75B | -63.65%2.22B | 11.74%6.1B | 45.64%5.46B | -18.66%3.75B | -27.35%4.61B | 58.68%6.34B | -40.08%4B | 306.33%6.67B | -30.92%1.64B |
Net profit before non-cash adjustment | 457.87%14.35B | 56.80%-4.01B | -56.18%-9.29B | -4,239.42%-5.95B | -114.35%-137M | 53.54%955M | -69.48%622M | 6.31%2.04B | -76.30%1.92B | 373.74%8.09B |
Total adjustment of non-cash items | -180.74%-5.52B | -31.48%6.84B | 21.43%9.98B | 60.87%8.22B | 18.38%5.11B | -13.80%4.32B | 34.53%5.01B | 18.28%3.72B | 149.96%3.15B | -229.20%-6.3B |
-Depreciation and amortization | -12.85%3.55B | -17.64%4.07B | -0.76%4.94B | 2.32%4.98B | 8.86%4.87B | -22.55%4.47B | 40.53%5.77B | 10.02%4.11B | 11.33%3.73B | -10.54%3.35B |
-Reversal of impairment losses recognized in profit and loss | --0 | --532M | --0 | --101M | ---- | ---- | --92M | ---- | ---- | -93.69%173M |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 103.48%44M | 43.92%-1.26B |
-Share of associates | -179.30%-1.81B | -49.39%2.29B | 108.16%4.52B | 818.21%2.17B | 73.46%-302M | 11.99%-1.14B | -13.72%-1.29B | 0.61%-1.14B | -42.64%-1.14B | -22.63%-802M |
-Disposal profit | -1,724.31%-7.68B | 333.00%473M | -256.15%-203M | -50.38%130M | 522.58%262M | 78.17%-62M | 30.39%-284M | -276.62%-408M | 102.92%231M | -679.49%-7.91B |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 234.01%197M | ---147M |
-Other non-cash items | 181.84%428M | -172.24%-523M | -13.50%724M | 197.86%837M | -73.08%281M | 45.40%1.04B | -38.00%718M | 1,278.57%1.16B | -71.81%84M | 497.33%298M |
Changes in working capital | -405.08%-3.08B | -111.28%-610M | 69.66%5.41B | 360.80%3.19B | -86.00%-1.22B | -192.02%-657M | 140.55%714M | -209.45%-1.76B | 1,172.67%1.61B | -132.75%-150M |
-Change in receivables | -82.15%-2.43B | -5,432.00%-1.33B | -99.17%25M | 1,410.48%3B | -149.25%-229M | 449.62%465M | 60.65%-133M | -269.85%-338M | 741.94%199M | -107.75%-31M |
-Change in inventory | -3,240.91%-691M | -69.44%22M | -94.39%72M | 576.95%1.28B | -320.31%-269M | 79.02%-64M | 14.33%-305M | -218.67%-356M | -60.21%300M | 364.56%754M |
-Change in payables | -78.36%179M | 444.08%827M | 115.95%152M | -29.13%-953M | 17.17%-738M | -177.14%-891M | 211.70%1.16B | -193.15%-1.03B | 227.15%1.11B | -354.52%-873M |
-Provision for loans, leases and other losses | -11.90%-141M | -102.44%-126M | 3,681.94%5.16B | -1,128.57%-144M | 108.38%14M | -5,466.67%-167M | -105.08%-3M | --59M | ---- | ---- |
-Changes in other current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---92M | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 4.23%-249M | 20.25%-260M | 30.34%-326M | -4.23%-468M | -6.15%-449M | 9.81%-423M | -1.96%-469M | 14.97%-460M | 2.52%-541M | -50.00%-555M |
Interest received (cash flow from operating activities) | 607.77%729M | -45.50%103M | 125.00%189M | -92.31%84M | 163.13%1.09B | -18.31%415M | -15.47%508M | 46.23%601M | -28.77%411M | 69.21%577M |
Tax refund paid | -29.32%-569M | -16.09%-440M | -49.80%-379M | 57.76%-253M | 4.31%-599M | 38.51%-626M | -54.95%-1.02B | -97.30%-657M | -162.20%-333M | 54.48%-127M |
Other operating cash inflow (outflow) | 0.00%1M | 200.00%1M | 0.00%-1M | 0.00%-1M | -1M | 0 | 0 | -2M | 0 | 0 |
Operating cash flow | 249.14%5.66B | -70.95%1.62B | 15.80%5.58B | 27.16%4.82B | -4.60%3.79B | -25.91%3.98B | 54.17%5.37B | -43.95%3.48B | 303.97%6.21B | -25.68%1.54B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 369.73%3.85B | 18.27%-1.43B | 68.20%-1.75B | -18.49%-5.49B | 9.39%-4.63B | -20.73%-5.11B | 24.44%-4.24B | -49.37%-5.61B | -172.94%-3.75B | 383.63%5.15B |
Net intangibles purchase and sale | -67.86%-47M | 56.92%-28M | 35.64%-65M | 39.88%-101M | -170.97%-168M | 31.11%-62M | 52.63%-90M | -630.77%-190M | 89.08%-26M | -453.49%-238M |
Net business purchase and sale | 639.79%2.1B | -52.82%284M | --602M | --0 | -384.95%-4.35B | ---897M | ---- | ---- | ---- | ---- |
Net investment product transactions | 102.65%14M | -177.79%-529M | 159.54%680M | -86.02%262M | 118.41%1.87B | 92.38%858M | -32.01%446M | 65,500.00%656M | -98.77%1M | 836.36%81M |
Advance cash and loans provided to other parties | 83.96%-210M | -21.88%-1.31B | -571.25%-1.07B | 81.31%-160M | -739.22%-856M | ---102M | --0 | 60.00%-2M | -66.67%-5M | ---3M |
Repayment of advance payments to other parties and cash income from loans | 2,794.74%2.2B | -33.91%76M | -66.57%115M | 67.80%344M | 10,150.00%205M | 0.00%2M | 0.00%2M | 0.00%2M | 0.00%2M | -60.00%2M |
Net changes in other investments | -2,742.86%-185M | 450.00%7M | -106.06%-2M | 112.27%33M | -2,590.00%-269M | 86.67%-10M | 83.62%-75M | 75.31%-458M | -92,850.00%-1.86B | 100.05%2M |
Investing cash flow | 363.91%7.72B | -96.38%-2.93B | 70.86%-1.49B | 37.63%-5.11B | -53.95%-8.2B | -34.71%-5.33B | 29.39%-3.95B | 0.67%-5.6B | -212.97%-5.64B | 189.44%4.99B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -603.17%-9.31B | 41.52%-1.32B | 28.89%-2.26B | -145.48%-3.18B | 226.39%7B | 469.83%2.15B | -118.88%-580M | 240.15%3.07B | -930.30%-2.19B | -93.69%264M |
Net common stock issuance | --0 | --0 | --0 | --0 | -16,250.00%-327M | -100.00%-2M | 50.00%-1M | 0.00%-2M | 0.00%-2M | 0.00%-2M |
Increase or decrease of lease financing | 15.27%-455M | 1.65%-537M | 24.48%-546M | 11.83%-723M | -115.22%-820M | 63.33%-381M | -320.59%-1.04B | 212.14%471M | -42.37%-420M | -85.53%-295M |
Cash dividends paid | 0.00%-2M | 99.03%-2M | 55.12%-206M | 12.57%-459M | -0.19%-525M | 0.19%-524M | -0.19%-525M | 0.19%-524M | 0.19%-525M | 8.84%-526M |
Cash dividends for minorities | -50.00%-9M | 0.00%-6M | -20.00%-6M | -25.00%-5M | -33.33%-4M | 0.00%-3M | 0.00%-3M | 0.00%-3M | 25.00%-3M | -33.33%-4M |
Net other fund-raising expenses | -1.48%-343M | 6.63%-338M | -119.92%-362M | 90,950.00%1.82B | 95.92%-2M | 36.36%-49M | 91.42%-77M | -1,280.00%-897M | -400.00%-65M | 38.10%-13M |
Financing cash flow | -358.50%-10.12B | 34.78%-2.21B | -32.50%-3.38B | -147.98%-2.55B | 348.82%5.32B | 153.30%1.19B | -205.10%-2.23B | 166.01%2.12B | -456.77%-3.21B | -116.83%-576M |
Net cash flow | ||||||||||
Beginning cash position | -31.51%7.46B | 9.58%10.9B | -23.17%9.95B | 19.07%12.95B | -2.87%10.87B | -7.37%11.19B | -1.10%12.08B | -17.69%12.22B | 67.66%14.84B | 0.52%8.85B |
Current changes in cash | 193.02%3.27B | -594.51%-3.51B | 124.96%710M | -410.25%-2.85B | 659.15%917M | 79.83%-164M | -81,200.00%-813M | 99.96%-1M | -144.27%-2.63B | 6,939.08%5.95B |
Effect of exchange rate changes | 2.60%79M | -55.23%77M | 198.85%172M | -309.64%-174M | 152.53%83M | -107.89%-158M | 50.33%-76M | -2,285.71%-153M | -82.50%7M | -50.00%40M |
Cash adjustments other than cash changes | --82M | ---- | 273.68%71M | -98.23%19M | 107,200.00%1.07B | 200.00%1M | -105.00%-1M | 1,900.00%20M | --1M | ---- |
End cash Position | 45.91%10.89B | -31.51%7.46B | 9.58%10.9B | -23.17%9.95B | 19.07%12.95B | -2.87%10.87B | -7.37%11.19B | -1.10%12.08B | -17.69%12.22B | 67.66%14.84B |
Free cash flow | 2,297.24%3.19B | -103.86%-145M | 576.05%3.76B | 22.27%-789M | 18.28%-1.02B | -221.88%-1.24B | 143.62%1.02B | -206.13%-2.34B | 191.63%2.2B | -1,901.67%-2.4B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |